Logotype for Suominen

Suominen (SUY1V) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Suominen

Q1 2026 earnings summary

12 May, 2026

Executive summary

  • Net sales for Q1 2026 declined 19% year-over-year to EUR 95.6 million, mainly due to lower volumes, currency effects, and lingering impacts from U.S. plant incidents in 2025.

  • Comparable EBITDA dropped to EUR 2.2 million from EUR 4.1 million, but improved slightly from Q4 2025.

  • Cash flow from operations improved to EUR 4.5 million, supported by working capital improvements and increased factoring.

  • A comprehensive three-year Full Potential Program was launched in January 2026 to restore profitability, targeting a 10% EBITDA margin by 2028.

  • A new operating model was adopted to enhance customer focus and manufacturing effectiveness.

Financial highlights

  • Net sales in Q1 2026 were EUR 95.6 million, reflecting lower volumes and a EUR -5.6 million currency impact.

  • Comparable EBITDA for Q1 2026 was EUR 2.2 million, down from EUR 4.1 million in Q1 2025.

  • Cash flow from operations improved to EUR 4.5 million, compared to EUR -0.4 million in Q1 2025, supported by a EUR 6.2 million positive change in net working capital.

  • Operating profit for Q1 2026 was EUR -4.4 million, with a net loss of EUR -5.7 million and EPS of EUR -0.10.

  • Share of new products in net sales was 26%, with a negative mix impact on profit.

Outlook and guidance

  • Comparable EBITDA is expected to increase in 2026 compared to 2025 (EUR 12.6 million in 2025).

  • The Full Potential Program aims to raise EBITDA margin from 3% to 10% by 2028 and reduce leverage to 2x–3x net debt/EBITDA.

  • Volume outlook for the rest of 2026 is higher than Q1, with order intake recovering, especially in the U.S.

  • Alicante line in Spain will start commercial production in May, with incremental margin benefits expected in H2 2026 and 2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more